イノベーションハブ
創薬のライフサイクルにおけるあらゆる段階の最新のブレイクスルー、技術、リソースをご紹介します。
Button Text






Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Disease Models
Columbus Instruments

ブログ
Podcast Q&A: Understanding Health Care Decision Maker Preferences for Optimized Engagement
6月 23, 2022
ブログを読む
Medical Communications
No items found.

ブログ
Podcast Q&A: FDA Guidance Documents: Shaping the Future of RWD Curation and RWE Innovation
5月 25, 2022
ブログを読む
Real-World Data (RWD)
Real-World Evidence (RWE)
No items found.

ブログ
Discovering a Novel Therapy for Urinary Tract Infections Through Outsourcing In-silico Drug Discovery
5月 12, 2022
ブログを読む
Pharmacology
No items found.
Health Economics & Outcomes Research (HEOR)
Boston Strategic Partners
Health Economics & Outcomes Research (HEOR)
HealthLumen

ブログ
Trends and challenges in the Value, Evidence, and Access landscape: an interview with David Sykes, Head of VEA, Fishawack Health
4月 21, 2022
スポンサー:
スポンサー
ブログを読む
Health Economics & Outcomes Research (HEOR)
Fishawack Health
Real-World Evidence (RWE)
Medical Communications
No items found.
Real-World Evidence (RWE)
Medical Communications
No items found.
Antibodies
DNA & RNA
Pharmacology
Protein Sciences
GenScript

ブログ
From Behind the Microscope to Under It: A Researcher's Experience Participating in a Clinical Trial
4月 4, 2022
ブログを読む
Clinical Trials
Pharmacology
No items found.
Health Economics & Outcomes Research (HEOR)
No items found.
Biomarkers
Clinical Trials
DMPK
Pharmacology
Brian Ogilvie
Joanna E. Barbara
BioIVT
No items found.
Biomarkers
Disease Models
In Vitro Assays
Pharmacology
Bioimaging
Toshiya Mashiko
Hiroshi Shimoyama
Axcelead Drug Discovery Partners, Inc.
No items found.
Biomarkers
Clinical Trials
Bioimaging
Protein Sciences
Kyung Chan Park
PROTEINA
No items found.
Chemical & Compound Analysis
Chemistry, Manufacturing & Controls
Discovery Chemistry
Pharmacology
Björn Borgström
RG Discovery
Pelago Bioscience
No items found.
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
John Kealy
Anne Sophie Michel
ICON
No items found.
Bioimaging
Cell Culture & Characterization
Disease Models
Instrumentation & Products
Biomarkers
Bong Ihn Koh
Pilhan Kim
IVIM Technology Inc.
No items found.
Biomarkers
Cell Culture & Characterization
Protein Sciences
Amanda Weaver
Colin McDowell
Biodesix
No items found.
Antibodies
In Vitro Assays
Cell Culture & Characterization
Pharmacology
Protein Sciences
Amanda Gross
KACTUS
No items found.
Cell Culture & Characterization
Disease Models
HBS
In Vitro Assays
NHBS
Koh Meng Aw Yong
Amir Nasajpour
Lonza Bioscience
Entropic Biosciences
No items found.
In Vitro Assays
DMPK
Toxicology
Lauren Brown
Alec Salminen
LifeNet Health LifeSciences
Scientist.com
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Mac Bonafede
Janna Manjelievskaia
Veradigm
No items found.
Disease Models
Biomarkers
Cell Culture & Characterization
In Vitro Assays
Pharmacology
Koji Murakami
Tomonori Kitaura
Axcelead Drug Discovery Partners, Inc.
No items found.
Clinical Trials
Disease Models
Cell Culture & Characterization
Disease Models

ポッドキャスト
Industry Insights with Amy Sheng on Nanobodies: An Important Tool for the Next Generation of Tumor Diagnostics and Therapeutics
9月 27, 2022
ポッドキャストを読む
Antibodies
Pharmacology
Disease Models
Instrumentation & Products
Disease Models
Pharmacology
Clinical Trials
Disease Models
No items found.

ポッドキャスト
#ExpertAnswers: Valeria Fumagalli and Nancy Kouassi on the Syrian golden hamster model of COVID-19
8月 18, 2022
ポッドキャストを読む
Disease Models
Toxicology
Antibodies
Biomarkers
Pharmacology
Real-World Evidence (RWE)
Medical Communications
Cell Culture & Characterization
Biomarkers
Pharmacology
DNA & RNA
No items found.
Clinical Trials
In Vitro Assays
Disease Models
Disease Models
Medical Communications
















.avif)

.avif)

















